---
input_text: 'Long-Term Outcomes of Hypertrophic Cardiomyopathy Diagnosed During Childhood:
  Results From a National Population-Based Study. BACKGROUND: Late survival and symptomatic
  status of children with hypertrophic cardiomyopathy have not been well defined.
  We examined long-term outcomes for pediatric hypertrophic cardiomyopathy. METHODS:
  The National Australian Childhood Cardiomyopathy Study is a longitudinal population-based
  cohort study of children (0-10 years of age) diagnosed with cardiomyopathy between
  1987 and 1996. The primary study end point was time to death or cardiac transplantation.
  RESULTS: There were 80 patients with hypertrophic cardiomyopathy, with a median
  age at diagnosis of 0.48 (interquartile range, 0.1, 2.5) years. Freedom from death/transplantation
  was 86% (95% confidence interval [CI], 77.0-92.0) 1 year after presentation, 80%
  (95% CI, 69.0-87.0) at 10 years, and 78% (95% CI, 67.0-86.0) at 20 years. From multivariable
  analyses, risk factors for death/transplantation included symmetrical left ventricular
  hypertrophy at the time of diagnosis (hazard ratio, 4.20; 95% CI, 1.60-11.05; P=0.004),
  Noonan syndrome (hazard ratio, 2.88; 95% CI, 1.02-8.08; P=0.045), higher posterior
  wall thickness z score (hazard ratio, 1.45; 95% CI, 1.22-1.73; P<0.001), and lower
  fractional shortening z score (hazard ratio, 0.84; 95% CI, 0.74-0.95; P=0.005) during
  follow-up. Nineteen (23%) subjects underwent left ventricular myectomy. At a median
  of 15.7 years of follow-up, 27 (42%) of 63 survivors were treated with beta-blocker,
  and 13 (21%) had an implantable cardioverter-defibrillator. CONCLUSIONS: The highest
  risk of death or transplantation for children with hypertrophic cardiomyopathy is
  within 1 year after diagnosis, with low attrition rates thereafter. Many subjects
  receive medical, surgical, or device therapy.'
raw_completion_output: |-
  primary_disease: Hypertrophic Cardiomyopathy

  medical_actions: Late survival and symptomatic status examination; National Australian Childhood Cardiomyopathy Study participation; Death or cardiac transplantation time measurement; Multivariable analyses for risk factor identification; Left ventricular myectomy; Beta-blocker treatment; Implantable cardioverter-defibrillator placement.

  symptoms: Symmetrical left ventricular hypertrophy; Higher posterior wall thickness z score; Lower fractional shortening z score.

  chemicals: Beta-blocker

  action_annotation_relationships: Left ventricular myectomy TREATS Symmetrical left ventricular hypertrophy IN Hypertrophic Cardiomyopathy; Beta-blocker treatment TREATS Higher posterior wall thickness z score IN Hypertrophic Cardiomyopathy; Implantable cardioverter-defibrillator placement TREATS Lower fractional shortening z score IN Hypertrophic Cardiomyopathy; Beta-blocker treatment TREATS Hypertrophic Cardiomyopathy.
prompt: |+
  Split the following piece of text into fields in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Beta-blocker treatment TREATS Hypertrophic Cardiomyopathy.

  ===

extracted_object:
  primary_disease: MONDO:0005045
  medical_actions:
    - Late survival and symptomatic status examination
    - National Australian Childhood Cardiomyopathy Study participation
    - Death or cardiac transplantation time measurement
    - Multivariable analyses for risk factor identification
    - Left ventricular myectomy
    - Beta-blocker treatment
    - Implantable cardioverter-defibrillator placement.
  symptoms:
    - Symmetrical left ventricular hypertrophy
    - Higher posterior wall thickness z score
    - Lower fractional shortening z score.
  chemicals:
    - CHEBI:35530
  action_annotation_relationships:
    - subject: Left ventricular myectomy
      predicate: TREATS
      object: Symmetrical left ventricular hypertrophy
      qualifier: MONDO:0005045
    - subject: treatment
      predicate: TREATS
      object: Higher posterior wall thickness z score
      qualifier: MONDO:0005045
      subject_extension: CHEBI:35530
    - subject: MAXO:0000474
      predicate: TREATS
      object: Lower fractional shortening z score
      qualifier: MONDO:0005045
    - subject: <treatment>
      predicate: <TREATS>
      object: <Hypertrophic Cardiomyopathy>
      subject_extension: <Beta-blocker>
named_entities:
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0006936
    label: pulmonary valve stenosis
  - id: MAXO:0009072
    label: surgical repair
  - id: MONDO:0018997
    label: Noonan syndrome
  - id: MAXO:0010203
    label: echocardiography
  - id: HP:0004322
    label: short stature
  - id: MONDO:0011908
    label: Juvenile myelomonocytic leukemia (JMML)
  - id: MAXO:0000747
    label: hematopoietic stem cell transplantation (HSCT)
  - id: HP:0001663
    label: ventricular fibrillation
  - id: HP:0001639
    label: hypertrophic cardiomyopathy
  - id: HP:0032092
    label: left ventricular outflow tract obstruction
  - id: HP:0030828
    label: Wheezing
  - id: CHEBI:90960
    label: Tiotropium (Tio)
  - id: MONDO:0007037
    label: Achondroplasia
  - id: CHEBI:37845
    label: Growth hormone (GH)
  - id: MONDO:0000050
    label: Growth Hormone Deficiency (GHD)
  - id: HP:0001510
    label: Poor growth
  - id: MONDO:0007414
    label: Gorham disease
  - id: MAXO:0000014
    label: Radiation therapy
  - id: HP:0012531
    label: Pain
  - id: HP:0010310
    label: Chylothorax
  - id: MONDO:0009735
    label: Tumorigenesis; Noonan syndrome (NS); LEOPARD syndrome (LS); Hematological
      malignancies; Solid tumors
  - id: MONDO:0007893
    label: Noonan syndrome with multiple lentigines
  - id: HP:0001670
    label: asymmetric septal hypertrophy
  - id: HP:0001631
    label: atrial septal defect
  - id: HP:0000818
    label: Endocrinopathies
  - id: HP:0000789
    label: Infertility
  - id: MONDO:0006769
    label: Gastroparesis
  - id: MAXO:0000079
    label: Genetic counseling
  - id: HP:0003270
    label: Bloating
  - id: CHEBI:31515
    label: Domperidone
  - id: MAXO:0010032
    label: heart transplantation
  - id: HP:0031318
    label: myofiber disarray
  - id: CHEBI:68478
    label: everolimus
  - id: MAXO:0001298
    label: therapy
  - id: MAXO:0000647
    label: Chemotherapy
  - id: MAXO:0025001
    label: cardiac surgery
  - id: HP:0001627
    label: congenital heart disease
  - id: HP:0001642
    label: pulmonary stenosis
  - id: MONDO:0007254
    label: Breast cancer
  - id: HP:0011675
    label: arrhythmias
  - id: HP:0002093
    label: respiratory insufficiency
  - id: HP:0002090
    label: pneumonia
  - id: MAXO:0035118
    label: Cardiac catheterization
  - id: HP:0001999
    label: Dysmorphic facial features
  - id: HP:0001684
    label: Secundum atrial septal defect
  - id: HP:0030957
    label: Ventricular septal aneurysm
  - id: HP:0002875
    label: Exertional dyspnea
  - id: HP:0000316
    label: Hypertelorism
  - id: HP:0000914
    label: Shield chest
  - id: HP:0002943
    label: Thoracic scoliosis
  - id: MONDO:0005212
    label: Rhabdomyosarcoma
  - id: HP:0001263
    label: Developmental delay
  - id: HP:0005152
    label: Congenital cardiomyopathy
  - id: HP:0002027
    label: Abdominal pain
  - id: HP:0002019
    label: Constipation
  - id: HP:0031500
    label: abdominal mass
  - id: HP:0001252
    label: hypotonia
  - id: HP:0001249
    label: intellectual disability
  - id: MONDO:0021200
    label: Rare diseases
  - id: MAXO:0000011
    label: Physiotherapy
  - id: MONDO:0001516
    label: spinal muscular atrophy
  - id: MONDO:0021060
    label: RASopathies
  - id: HP:0010816
    label: Epidermal nevi
  - id: HP:0010815
    label: Nevus sebaceous
  - id: MONDO:0007783
    label: King syndrome
  - id: HP:0001787
    label: delivery complications
  - id: HP:0011001
    label: Increased bone mineral density
  - id: MAXO:0000068
    label: Transplantation
  - id: MONDO:0006664
    label: atrial septal defect
  - id: HP:0003010
    label: Prolonged bleeding time
  - id: CHEBI:4450
    label: Desmopressin
  - id: CHEBI:15365
    label: Aspirin
  - id: MONDO:0019565
    label: von Willebrand disease
  - id: HP:0002089
    label: Pulmonary hypoplasia
  - id: HP:0001256
    label: mild mental retardation
  - id: HP:0000365
    label: deafness
  - id: HP:0030692
    label: brain tumors
  - id: HP:0001635
    label: Congestive heart failure
  - id: CHEBI:119915
    label: Fentanyl
  - id: CHEBI:6931
    label: Midazolam
  - id: CHEBI:44915
    label: Propofol
  - id: CHEBI:6121
    label: Ketamine
  - id: CHEBI:9130
    label: Sevoflurane
  - id: HP:0001508
    label: failure to thrive
  - id: CHEBI:8499
    label: propranolol
  - id: CHEBI:135083
    label: cibenzoline
  - id: MONDO:0015280
    label: Cardiofaciocutaneous syndrome
  - id: HP:0032152
    label: Keratosis pilaris
  - id: HP:0100837
    label: Ulerythema ophryogenes
  - id: HP:0000972
    label: Palmoplantar hyperkeratosis
  - id: CHEBI:9168
    label: Sirolimus
  - id: CHEBI:50172
    label: Acitretin
  - id: MAXO:0000502
    label: Endotracheal intubation
  - id: CHEBI:31696
    label: Indocyanine green
  - id: MAXO:0035035
    label: lymphography
  - id: MAXO:0000127
    label: Genetic testing
  - id: HP:0000252
    label: Microcephaly
  - id: HP:0001680
    label: aortic coarctation
  - id: MONDO:0019383
    label: Acute Disseminated Encephalomyelitis
  - id: HP:0001945
    label: fever
  - id: HP:0002329
    label: drowsiness
  - id: CHEBI:6888
    label: methylprednisolone
  - id: MONDO:0009369
    label: Nonimmune hydrops fetalis (NIHF)
  - id: HP:0001790
    label: Nonimmune hydrops fetalis
  - id: CHEBI:40303
    label: Lovastatin
  - id: CHEBI:38637
    label: tyrosine kinase inhibitors
  - id: CHEBI:79091
    label: MEK inhibitors
  - id: HP:0001649
    label: tachycardia
  - id: HP:0002615
    label: hypotension
  - id: HP:0001942
    label: metabolic acidosis
  - id: CHEBI:6872
    label: Methylene Blue
  - id: CHEBI:18357
    label: norepinephrine
  - id: CHEBI:18243
    label: dopamine
  - id: CHEBI:9937
    label: vasopressin
  - id: HP:0009732
    label: plexiform neurofibromas (PNs)
  - id: CHEBI:90227
    label: selumetinib
  - id: MAXO:0000780
    label: growth hormone therapy
  - id: MONDO:0005045
    label: hypertrophic obstructive cardiomyopathy
  - id: MAXO:0001490
    label: Platelet transfusions
  - id: HP:0002878
    label: Respiratory failure
  - id: MAXO:0000756
    label: transfusions
  - id: MONDO:0011331
    label: Congenital chylothorax
  - id: HP:0000028
    label: cryptorchidism
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0004349
    label: Decreased bone mineral density
  - id: CHEBI:10033
    label: Warfarin
  - id: CHEBI:8093
    label: Phenylephrine
  - id: HP:0002650
    label: Scoliosis
  - id: HP:0001655
    label: Patent foramen ovale
  - id: HP:0012905
    label: Euryblepharon
  - id: HP:0030001
    label: Lagophthalmos
  - id: HP:0000271
    label: Facial anomalies
  - id: MONDO:0015340
    label: DRESS syndrome
  - id: HP:0000988
    label: Rash
  - id: HP:0001880
    label: Eosinophilia
  - id: CHEBI:134975
    label: fluindione
  - id: CHEBI:50858
    label: corticosteroids
  - id: CHEBI:53766
    label: acenocoumarol
  - id: CHEBI:50249
    label: anticoagulant
  - id: MONDO:0017326
    label: Intraduodenal hematoma (IDH)
  - id: HP:0005214
    label: Intestinal obstruction
  - id: HP:0002013
    label: Vomiting
  - id: HP:0001735
    label: Acute pancreatitis
  - id: MONDO:0000565
    label: Infective endocarditis
  - id: HP:0001698
    label: Pericardial effusion
  - id: MONDO:0006450
    label: Therapy-related Myeloid Neoplasms (t-MN)
  - id: HP:0001873
    label: Thrombocytopenia
  - id: MONDO:0017014
    label: children
  - id: MAXO:0009004
    label: whole exome sequencing
  - id: HP:0000969
    label: Hydrops
  - id: HP:0025678
    label: fetal hydrothorax
  - id: MAXO:0000526
    label: Clinical examination
  - id: MONDO:0006235
    label: granular cell tumour (GCT)
  - id: HP:0500092
    label: Orbital rhabdomyosarcoma
  - id: HP:0025677
    label: Fetal chylothorax
  - id: MAXO:0001175
    label: Liver Transplantation
  - id: MONDO:0021548
    label: Congenital chylothorax (CCT)
  - id: MAXO:0000503
    label: mechanical ventilation
  - id: CHEBI:7726
    label: octreotide
  - id: CHEBI:64628
    label: somatostatin
  - id: MONDO:0007316
    label: Chiari malformation Type I (CM-I)
  - id: MAXO:0000004
    label: surgery
  - id: HP:0002277
    label: Horner syndrome
  - id: HP:0002094
    label: dyspnea
  - id: MONDO:0006770
    label: Central giant cell granuloma
  - id: HP:0000083
    label: renal failure
  - id: HP:0003774
    label: Chronic renal failure
  - id: HP:0001511
    label: Intrauterine growth retardation
  - id: HP:0000824
    label: Growth hormone deficiency
  - id: MONDO:0019499
    label: Turner syndrome
  - id: MONDO:0024327
    label: Chronic renal failure
  - id: MONDO:0008300
    label: Prader-Willi syndrome
  - id: MONDO:0005030
    label: Intrauterine growth retardation
  - id: CHEBI:35530
    label: Beta-blocker
  - id: MAXO:0000474
    label: Implantable cardioverter-defibrillator placement
